🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
It is expected that addition of anti-CD20 antibody - ofatumumab would enhan...
Status
Completed
Location
Dolnośląskie Centrum Transplantacji Komórkowych
Start Date
2011-11
Trial ID
NCT01481272
The purpose of this study is to: Investigate the Overall Response Rate (ORR...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2010-07
Trial ID
NCT01119794
Treatments Being Tested
This phase II trial studies the side effects and how well combination chemo...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-08-09
Trial ID
NCT03136146
This is an open-label study to evaluate tolerability, safety, efficacy and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04
Trial ID
NCT01563055
Treatments Being Tested
A 3-year open-label trial for patients who previously participated in Trial...
Status
Terminated
Location
GSK Investigational Site
Start Date
2008-01-01
Trial ID
NCT00655824
Treatments Being Tested
This was a non-interventional, retrospective, observational cohort study in...
Status
Completed
Location
Novartis
Start Date
2022-05-20
Trial ID
NCT06460324
This is a single-arm, Phase II study designed to enroll and treat up to 64 ...
Status
Completed
Location
Florida Cancer Specialists-South
Start Date
2012-10
Trial ID
NCT01626352
Treatments Being Tested
The purpose of this research is to evaluate the safety and effectiveness of...
Status
Completed
Location
Medical University of South Carolina
Start Date
2010-05
Trial ID
NCT01123356
Treatments Being Tested
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Terminated
Location
Novartis Investigational Site
Start Date
2013-08-13
Trial ID
NCT01920477
Treatments Being Tested
This phase II trial studies how well ofatumumab in combination with cycloph...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2011-12-06
Trial ID
NCT01527149